Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Merrill JT, Ginzler EM, Wallace DJ, McKay JD, Lisse JR, Aranow C, Wellborne FR, Burnette M, Condemi J, Zhong ZJ, Pineda L, Klein J, Freimuth WW; LBSL02/99 Study Group.
Merrill JT, et al. Among authors: wellborne fr.
Arthritis Rheum. 2012 Oct;64(10):3364-73. doi: 10.1002/art.34564.
Arthritis Rheum. 2012.
PMID: 22674457
Free article.
Clinical Trial.